SG11201401570YA - Pharmaceutical compositions of resveratrol - Google Patents
Pharmaceutical compositions of resveratrolInfo
- Publication number
- SG11201401570YA SG11201401570YA SG11201401570YA SG11201401570YA SG11201401570YA SG 11201401570Y A SG11201401570Y A SG 11201401570YA SG 11201401570Y A SG11201401570Y A SG 11201401570YA SG 11201401570Y A SG11201401570Y A SG 11201401570YA SG 11201401570Y A SG11201401570Y A SG 11201401570YA
- Authority
- SG
- Singapore
- Prior art keywords
- resveratrol
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 title 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical group C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229940016667 resveratrol Drugs 0.000 title 1
- 235000021283 resveratrol Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2011904326A AU2011904326A0 (en) | 2011-10-19 | Pharmaceutical Formulations of Resveratrol and Methods of Use Thereof For Treating Cell Disorders | |
PCT/AU2012/001253 WO2013056298A1 (en) | 2011-10-19 | 2012-10-17 | Pharmaceutical compositions of resveratrol |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201401570YA true SG11201401570YA (en) | 2014-05-29 |
Family
ID=48140220
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201401570YA SG11201401570YA (en) | 2011-10-19 | 2012-10-17 | Pharmaceutical compositions of resveratrol |
Country Status (8)
Country | Link |
---|---|
US (1) | US20140303260A1 (en) |
EP (1) | EP2768489A4 (en) |
JP (1) | JP2014530823A (en) |
KR (1) | KR20140108633A (en) |
AU (1) | AU2012325668A1 (en) |
CA (1) | CA2852968A1 (en) |
SG (1) | SG11201401570YA (en) |
WO (1) | WO2013056298A1 (en) |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60146834A (en) * | 1983-12-29 | 1985-08-02 | Kitasato Inst:The | Production of antibody for inhibiting periodontitis and noncarious composition containing said antibody |
US4824680A (en) * | 1988-05-19 | 1989-04-25 | Wm. Wrigley, Jr. Company | Non-staling gum composition with improved wrappability |
AU5565696A (en) * | 1995-04-24 | 1996-11-18 | Wm. Wrigley Jr. Company | Method for manufacturing chewing gum |
WO2000038620A2 (en) * | 1998-12-24 | 2000-07-06 | 1333366 Ontario Inc. | A composition useful to treat periodontal disease |
PE20010540A1 (en) * | 1999-07-30 | 2001-05-15 | Procter & Gamble | COMPOSITION OF STYLBENE PHYTOALEXINS USEFUL FOR PROPHYLAXIS AND TREATMENT OF SYMPTOMS ASSOCIATED WITH COLD AND INFLUENZA-SIMILAR DISEASES |
US20040013752A1 (en) * | 2002-07-05 | 2004-01-22 | Wolfson Philip E. | Buccal and sublingual mucosally absorbed herbal compositions for relieving nicotine withdrawal symptoms and craving for nicotine and nicotine containing substances |
CN101170913A (en) * | 2005-04-29 | 2008-04-30 | Wm.雷格利Jr.公司 | Shaped chewing gum products and methods of making same |
WO2009089334A1 (en) * | 2008-01-08 | 2009-07-16 | David Rubin | Method and compositions for preserving wine |
WO2009108999A1 (en) * | 2008-03-03 | 2009-09-11 | Ross Stewart Grant | Pharmaceutical formulations of resveratrol and methods of use thereof for treating cell disorders |
US9125858B2 (en) * | 2009-11-30 | 2015-09-08 | Wilmore Labs L.L.C. | Compositions and methods relating to resveratrol |
-
2012
- 2012-10-17 CA CA2852968A patent/CA2852968A1/en not_active Abandoned
- 2012-10-17 JP JP2014536064A patent/JP2014530823A/en active Pending
- 2012-10-17 AU AU2012325668A patent/AU2012325668A1/en not_active Abandoned
- 2012-10-17 KR KR1020147013243A patent/KR20140108633A/en not_active Application Discontinuation
- 2012-10-17 EP EP12841469.5A patent/EP2768489A4/en not_active Withdrawn
- 2012-10-17 WO PCT/AU2012/001253 patent/WO2013056298A1/en active Application Filing
- 2012-10-17 SG SG11201401570YA patent/SG11201401570YA/en unknown
- 2012-10-17 US US14/352,822 patent/US20140303260A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2768489A1 (en) | 2014-08-27 |
US20140303260A1 (en) | 2014-10-09 |
JP2014530823A (en) | 2014-11-20 |
CA2852968A1 (en) | 2013-04-25 |
WO2013056298A1 (en) | 2013-04-25 |
KR20140108633A (en) | 2014-09-12 |
AU2012325668A1 (en) | 2014-05-08 |
EP2768489A4 (en) | 2015-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1210706A1 (en) | Inhalable pharmaceutical compositions | |
AP3864A (en) | Pharmaceutical composition | |
IL230010B (en) | Inhalable pharmaceutical compositions | |
GB201113662D0 (en) | Pharmaceutical compositions | |
ZA201308208B (en) | Pharmaceutical compositions | |
HK1199824A1 (en) | Pharmaceutical compositions | |
GB201118232D0 (en) | Pharmaceutical composition | |
EP2731605A4 (en) | Pharmaceutical compositions for rectal administration | |
EP2702989A4 (en) | Stable pharmaceutical composition | |
IL237139A0 (en) | Pharmaceutical compositions of memantine | |
HRP20180567T1 (en) | Pharmaceutical composition of omeprazole | |
HK1189158A1 (en) | Pharmaceutical composition | |
EP2769718A4 (en) | Medicinal composition | |
GB201118181D0 (en) | Pharmaceutical compositions | |
ZA201402165B (en) | Compositions of lopinavir | |
EP2727593A4 (en) | Nicorandil-containing pharmaceutical composition | |
EP2711010A4 (en) | Pharmaceutical composition | |
HUP1100444A2 (en) | Pharmaceutical composition | |
ZA201308414B (en) | Solid pharmaceutical composition | |
GB201100786D0 (en) | Pharmaceutical compositions of immunosuppressants | |
EP2714715A4 (en) | Pharmaceutical compositions | |
HUP1100445A2 (en) | Pharmaceutical composition | |
SG11201401570YA (en) | Pharmaceutical compositions of resveratrol | |
ZA201309537B (en) | Pharmaceutical composition comprising fexofedine | |
GB201105224D0 (en) | Novel pharmaceutical compositions |